Cresco Labs Inc. (OTCMKTS:CRLBF) Receives Average Rating of “Buy” from Brokerages

Shares of Cresco Labs Inc. (OTCMKTS:CRLBF) have been given a consensus rating of “Buy” by the four brokerages that are currently covering the stock, Marketbeat Ratings reports. Two analysts have rated the stock with a hold rating and two have given a strong buy rating to the company.

A number of equities research analysts have recently commented on the stock. Cormark raised shares of Cresco Labs from a “hold” rating to a “moderate buy” rating in a research note on Monday, March 17th. Canaccord Genuity Group lowered Cresco Labs from a “strong-buy” rating to a “moderate buy” rating in a report on Tuesday, June 3rd.

Cresco Labs Price Performance

Shares of OTCMKTS:CRLBF opened at $0.52 on Friday. Cresco Labs has a twelve month low of $0.49 and a twelve month high of $2.05. The company’s 50 day moving average is $0.68 and its 200 day moving average is $0.82. The company has a current ratio of 1.97, a quick ratio of 1.39 and a debt-to-equity ratio of 1.80. The company has a market cap of $252.87 million, a PE ratio of -2.58 and a beta of 1.47.

Cresco Labs (OTCMKTS:CRLBF) last issued its quarterly earnings results on Friday, May 30th. The company reported ($0.04) earnings per share for the quarter, missing the consensus estimate of ($0.03) by ($0.01). The business had revenue of $165.76 million during the quarter, compared to analyst estimates of $164.37 million. Cresco Labs had a negative return on equity of 16.52% and a negative net margin of 9.15%. On average, sell-side analysts forecast that Cresco Labs will post -0.2 EPS for the current year.

Cresco Labs Company Profile

Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.